Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
---|---|---|---|---|---|
Revenue | -84.55% | -- | -- | -- | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -84.55% | -- | -- | -- | |
Cost of Revenue | -- | -- | -- | -- | |
Gross Profit | -84.55% | -- | -- | -- | |
SG&A Expenses | 273.15% | -- | -- | -- | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 188.47% | -- | -- | -- | |
Operating Income | -243.33% | -- | -- | -- | |
Income Before Tax | -218.05% | -- | -- | -- | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -218.10% | -- | -- | -- | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -218.10% | -- | -- | -- | |
EBIT | -243.33% | -- | -- | -- | |
EBITDA | -198.48% | -- | -- | -- | |
EPS Basic | -19.25% | -- | -- | -- | |
Normalized Basic EPS | -7.17% | -- | -- | -- | |
EPS Diluted | -19.25% | -- | -- | -- | |
Normalized Diluted EPS | -7.17% | -- | -- | -- | |
Average Basic Shares Outstanding | 138.84% | -- | -- | -- | |
Average Diluted Shares Outstanding | 138.84% | -- | -- | -- | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |